Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections
Authors:
- Ayşe ErbayAEAyşe Erbay
- Aysun İdIlAIAysun İdIl
- M. Gökhan GözelMGM. Gökhan Gözel
- İpek MumcuoğluİMİpek Mumcuoğlu
- Neriman BalabanNBNeriman Balaban
- 1 December 2009
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 34 (6) , 575-579
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Broad‐Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up FrontClinical Infectious Diseases, 2008
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment OptionsClinical Infectious Diseases, 2008
- Attributable Mortality of Nosocomial Acinetobacter BacteremiaInfection Control & Hospital Epidemiology, 2007
- Attributable mortality of Acinetobacter baumannii: no longer a controversial issueCritical Care, 2007
- The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomesJournal of Hospital Infection, 2006
- Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapyJournal of Antimicrobial Chemotherapy, 2006
- Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002Journal of Hospital Infection, 2006
- Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsisThe American Journal of Medicine, 2003
- Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatmentClinical Microbiology and Infection, 2002
- Nosocomial Bacteremia due to Acinetobacter baumannii: Clinical Features, Epidemiology, and Predictors of MortalityMedicine, 1995